Robotic-assisted percutaneous coronary intervention in the COVID-19 pandemic

Area of Science:

• Cardiovascular Medicine
• Medical Technology
• Infectious Disease Control

Background:

• The COVID-19 pandemic significantly impacted healthcare, necessitating the suspension of elective procedures to conserve resources and prevent nosocomial infections.
• Emergency interventions for life-threatening cardiovascular conditions like acute coronary syndrome and cardiogenic shock remain critical.
• Social distancing is paramount during the pandemic, posing challenges for traditional procedures requiring close patient contact.

Purpose of the Study:

• To evaluate the role of robotic-assisted percutaneous coronary intervention (R-PCI) in managing cardiovascular emergencies during the COVID-19 pandemic.
• To assess the potential of R-PCI in minimizing healthcare worker exposure to the SARS-CoV-2 virus.
• To explore how R-PCI can maintain essential cardiovascular care while adhering to infection control measures.

Main Methods:

• Utilized robotic-assisted percutaneous coronary intervention (R-PCI) systems for emergency cardiovascular procedures.
• Implemented remote manipulation of devices from a cockpit situated meters away from the patient.
• Maintained standard infection control protocols alongside the R-PCI procedure.

Main Results:

• Robotic-assisted PCI enables operators to perform procedures remotely, significantly increasing distance from the patient.
• The system allows for reduced person-to-person contact during catheterization procedures.
• This approach has the potential to decrease the risk of viral transmission to healthcare professionals.

Conclusions:

• Robotic-assisted PCI is a viable strategy for managing critical cardiovascular conditions during pandemics like COVID-19.
• R-PCI enhances safety for medical staff by minimizing exposure to potentially infected patients.
• The technology supports the continuation of essential cardiovascular interventions while upholding public health guidelines.